Markus Hambek

1.1k total citations
45 papers, 867 citations indexed

About

Markus Hambek is a scholar working on Oncology, Molecular Biology and Otorhinolaryngology. According to data from OpenAlex, Markus Hambek has authored 45 papers receiving a total of 867 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 17 papers in Molecular Biology and 16 papers in Otorhinolaryngology. Recurrent topics in Markus Hambek's work include Head and Neck Cancer Studies (16 papers), HER2/EGFR in Cancer Research (7 papers) and Lung Cancer Treatments and Mutations (6 papers). Markus Hambek is often cited by papers focused on Head and Neck Cancer Studies (16 papers), HER2/EGFR in Cancer Research (7 papers) and Lung Cancer Treatments and Mutations (6 papers). Markus Hambek collaborates with scholars based in Germany, Austria and United States. Markus Hambek's co-authors include Wolfgang Gstœttner, Rainald Knecht, Oliver F. Adunka, Marc H. Unkelbach, Jan Kiefer, Mehran Baghi, Martin G. Mack, Jens Wagenblast, Wolfgang Gstöttner and Andreas Radeloff and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and European Journal of Cancer.

In The Last Decade

Markus Hambek

45 papers receiving 849 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Markus Hambek Germany 16 304 245 244 195 147 45 867
Joni K. Doherty United States 21 303 1.0× 472 1.9× 209 0.9× 369 1.9× 241 1.6× 62 1.4k
William W. M. Lo United States 22 365 1.2× 448 1.8× 225 0.9× 228 1.2× 103 0.7× 43 1.4k
Annekatrin Coordes Germany 15 256 0.8× 165 0.7× 135 0.6× 136 0.7× 129 0.9× 47 655
Friedrich Ihler Germany 21 692 2.3× 205 0.8× 184 0.8× 302 1.5× 167 1.1× 87 1.4k
Miha Žargi Slovenia 20 349 1.1× 153 0.6× 122 0.5× 35 0.2× 71 0.5× 59 1.0k
Gábor Répássy Hungary 16 233 0.8× 246 1.0× 70 0.3× 129 0.7× 198 1.3× 47 733
Linda X. Yin United States 20 419 1.4× 234 1.0× 81 0.3× 67 0.3× 98 0.7× 91 1.1k
Katrina R. Stidham United States 11 208 0.7× 201 0.8× 201 0.8× 154 0.8× 62 0.4× 28 625
Masaaki Kitahara Japan 23 199 0.7× 506 2.1× 107 0.4× 541 2.8× 167 1.1× 134 1.8k
Wong‐Kein Low Singapore 18 342 1.1× 348 1.4× 92 0.4× 219 1.1× 52 0.4× 56 902

Countries citing papers authored by Markus Hambek

Since Specialization
Citations

This map shows the geographic impact of Markus Hambek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Hambek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Hambek more than expected).

Fields of papers citing papers by Markus Hambek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Hambek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Hambek. The network helps show where Markus Hambek may publish in the future.

Co-authorship network of co-authors of Markus Hambek

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Hambek. A scholar is included among the top collaborators of Markus Hambek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Hambek. Markus Hambek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hambek, Markus, Änne Eckardt, Christoph Arnoldner, et al.. (2012). The role of recombinant epidermal growth factor and serotonin in the stimulation of tumor growth in a SCCHN xenograft model. Oncology Reports. 28(3). 785–790. 6 indexed citations
2.
Wagenblast, Jens, Änne Eckardt, Martin Leinung, et al.. (2012). Antitumoral effect of PLK-1-inhibitor BI2536 in combination with cisplatin and docetaxel in squamous cell carcinoma cell lines of the head and neck. Molecular and Clinical Oncology. 1(2). 286–290. 6 indexed citations
3.
Balermpas, Panagiotis, C. Keller, Markus Hambek, et al.. (2012). Reirradiation With Cetuximab in Locoregional Recurrent and Inoperable Squamous Cell Carcinoma of the Head and Neck: Feasibility and First Efficacy Results. International Journal of Radiation Oncology*Biology*Physics. 83(3). e377–e383. 27 indexed citations
4.
Schell, Boris, Ralf W. Bauer, Thomas Lehnert, et al.. (2010). Low-dose computed tomography of the paranasal sinus and facial skull using a high-pitch dual-source system—First clinical results. European Radiology. 21(1). 107–112. 29 indexed citations
5.
Bisdas, Sotirios, Zoran Rumboldt, Jens Wagenblast, et al.. (2009). Response and Progression-Free Survival in Oropharynx Squamous Cell Carcinoma Assessed by Pretreatment Perfusion CT: Comparison with Tumor Volume Measurements. American Journal of Neuroradiology. 30(4). 793–799. 20 indexed citations
6.
Wagenblast, Jens, Mehran Baghi, Christoph Arnoldner, et al.. (2008). Cetuximab enhances the efficacy of bortezomib in squamous cell carcinoma cell lines. Journal of Cancer Research and Clinical Oncology. 135(3). 387–393. 14 indexed citations
7.
Wagenblast, Jens, et al.. (2008). Pre‐treatment haemoglobin level predicts response and survival after TPF induction polychemotherapy in advanced head and neck cancer patients. Clinical Otolaryngology. 33(3). 245–251. 8 indexed citations
8.
Baghi, Mehran, Jens Wagenblast, Markus Hambek, et al.. (2007). Demands on Caring Relatives of Head and Neck Cancer Patients. The Laryngoscope. 117(4). 712–716. 34 indexed citations
9.
Wagenblast, Jens, Markus Hambek, Mehran Baghi, et al.. (2007). Antiproliferative activity of bortezomib alone and in combination with cisplatin or docetaxel in head and neck squamous cell carcinoma cell lines. Journal of Cancer Research and Clinical Oncology. 134(3). 323–330. 17 indexed citations
10.
Hambek, Markus, Christian Werner, Mehran Baghi, Wolfgang Gstöttner, & Rainald Knecht. (2007). Enhancement of docetaxel efficacy in head and neck cancer treatment by G0 cell stimulation. European Journal of Cancer. 43(10). 1502–1507. 10 indexed citations
11.
Bisdas, Sotirios, Knut Engels, Meysam Yousefi, et al.. (2007). Prognostic relevance of volumetric analysis in tumour specimens of hypopharyngeal cancer. Clinical Otolaryngology. 32(5). 372–377. 8 indexed citations
12.
Hambek, Markus, et al.. (2006). Inverse correlation between serum PGE2 and T classification in head and neck cancer. Head & Neck. 29(3). 244–248. 31 indexed citations
13.
Hambek, Markus, Oliver F. Adunka, Mehran Baghi, Wolfgang Gstœttner, & Rainald Knecht. (2006). AdOnco: A Database for Clinical and Scientific Documentation of Head and Neck Oncology. Annals of Otology Rhinology & Laryngology. 115(2). 144–149. 8 indexed citations
14.
Habtemichael, Negusse, Carina Ittrich, Grischa Toedt, et al.. (2005). Patient-based cross-platform comparison of oligonucleotide microarray expression profiles. Laboratory Investigation. 85(8). 1024–1039. 52 indexed citations
15.
Adunka, Oliver F., Wolfgang Gstœttner, Markus Hambek, et al.. (2004). Preservation of Basal Inner Ear Structures in Cochlear Implantation. ORL. 66(6). 306–312. 84 indexed citations
16.
Hambek, Markus, et al.. (2004). Tissue-Microarrays. HNO. 52(5). 409–412. 3 indexed citations
17.
Adunka, Oliver F., et al.. (2004). AdOnco. HNO. 53(1). 39–45. 3 indexed citations
18.
Adunka, Oliver F., Marc H. Unkelbach, Martin G. Mack, et al.. (2004). Cochlear implantation via the round window membrane minimizes trauma to cochlear structures: A histologically controlled insertion study. Acta Oto-Laryngologica. 124(7). 807–812. 188 indexed citations
19.
Knecht, Rainald, et al.. (2004). EGFR-Antibody-Supplemented TPF Chemotherapy. Advances in oto-rhino-laryngology. 62. 81–91. 1 indexed citations
20.
Hambek, Markus, Christine Solbach, M. Roller, et al.. (2001). Tumor necrosis factor alpha sensitizes low epidermal growth factor receptor (EGFR)-expressing carcinomas for anti-EGFR therapy.. PubMed. 61(3). 1045–9. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joni K. Doherty Breakdown of academic impact, for papers by William W. M. Lo Breakdown of academic impact, for papers by Annekatrin Coordes Breakdown of academic impact, for papers by Friedrich Ihler Breakdown of academic impact, for papers by Miha Žargi Breakdown of academic impact, for papers by Gábor Répássy Breakdown of academic impact, for papers by Linda X. Yin Breakdown of academic impact, for papers by Katrina R. Stidham Breakdown of academic impact, for papers by Masaaki Kitahara Breakdown of academic impact, for papers by Wong‐Kein Low
Rankless by CCL
2026